We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$147B
1-Year Est. Return
18.73%
This Fund
S&P 500
This Quarter
Est. Return
-6.34%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$57.8B
AUM Growth
-$2.88B
(-4.8%)
Cap. Flow
+$1.24B
Cap. Flow
% of AUM
2.14%
Top 10 Holdings %
Top 10 Hldgs %
45.42%
Holding
2,491
New
223
Increased
1,138
Reduced
765
Closed
178
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Large- Cap ETF
SCHX
|
+$445M |
| 2 |
Vanguard Total Bond Market
BND
|
+$212M |
| 3 |
Vanguard Large-Cap ETF
VV
|
+$175M |
| 4 |
iShares Core MSCI International Developed Markets ETF
IDEV
|
+$126M |
| 5 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$118M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$168M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$109M |
| 3 |
Vanguard Total Stock Market ETF
VTI
|
+$90.7M |
| 4 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$81M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$75.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.36% |
| 2 | Financials | 2.9% |
| 3 | Consumer Discretionary | 1.73% |
| 4 | Healthcare | 1.64% |
| 5 | Consumer Staples | 1.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2151
Fuel Tech
FTEK
$48M
| $32K | ﹤0.01% |
27,350
+3,500
| +15% | +$4.54K |
|
2152
CALL
Intel
INTC
$464B
| $32K | ﹤0.01% |
11,500
+4,200
| +58% | +$143K |
|
|
LOGC
2153
DELISTED
ContextLogic
LOGC
| $32K | ﹤0.01% |
1,464
-10
| -0.7% | -$414 |
|
|
ML
2154
DELISTED
MoneyLion Inc.
ML
| $32K | ﹤0.01% |
+1,183
| New | +$54.3K |
|
|
DOCU
2155
CALL
DocuSign
DOCU
$9.63B
| $31K | ﹤0.01% |
2,500
| – | – |
|
2156
Perspective Therapeutics
CATX
$332M
| $30K | ﹤0.01% |
12,950
| – | – |
|
2157
Lineage Cell Therapeutics
LCTX
$257M
| $30K | ﹤0.01% |
26,368
+66
| +0.3% | +$97 |
|
2158
PUT
UnitedHealth
UNH
$382B
| $30K | ﹤0.01% |
+5,100
| New | +$2.68M |
|
2159
Cytosorbents Corp
CTSO
$22.6M
| $29K | ﹤0.01% |
21,295
-2,120
| -9% | -$4.14K |
|
2160
Journey Medical
DERM
$170M
| $29K | ﹤0.01% |
11,764
| – | – |
|
2161
Corvex Inc
MOVE
$345M
| $29K | ﹤0.01% |
96
| – | – |
|
2162
Local Bounti
LOCL
$24.2M
| $28K | ﹤0.01% |
769
| – | – |
|
2163
Outlook Therapeutics
OTLK
$264M
| $28K | ﹤0.01% |
1,150
| – | – |
|
2164
Gevo
GEVO
$397M
| $27K | ﹤0.01% |
11,947
-5,680
| -32% | -$15.8K |
|
2165
CALL
Newmont
NEM
$99.5B
| $27K | ﹤0.01% |
+10,000
| New | +$467K |
|
2166
Nuvation Bio
NUVB
$2.24B
| $27K | ﹤0.01% |
12,079
| – | – |
|
2167
PUT
Moderna
MRNA
$21.5B
| $26K | ﹤0.01% |
14,800
| – | – |
|
|
SVM
2168
Silvercorp Metals
SVM
$2.13B
| $26K | ﹤0.01% |
11,105
+338
| +3% | +$813 |
|
|
URG
2169
Ur-Energy
URG
$485M
| $26K | ﹤0.01% |
24,135
| – | – |
|
2170
PUT
Wells Fargo
WFC
$261B
| $24K | ﹤0.01% |
15,000
-17,500
| -54% | -$752K |
|
2171
Xos
XOS
$27.7M
| $24K | ﹤0.01% |
666
+282
| +73% | +$14.5K |
|
2172
PUT
McDonald's
MCD
$188B
| $23K | ﹤0.01% |
5,000
| – | – |
|
|
LCI
2173
DELISTED
Lannett Company, Inc.
LCI
| $23K | ﹤0.01% |
12,500
| – | – |
|
|
MREO
2174
Mereo BioPharma
MREO
$45.9M
| $22K | ﹤0.01% |
+25,820
| New | +$31.6K |
|
|
SOND
2175
DELISTED
Sonder
SOND
| $22K | ﹤0.01% |
+676
| New | +$22.5K |
|
Similar funds
Creative Planning's Q3 2022 Portfolio in Review
As of Q3 2022, Creative Planning held 2,491 positions worth $57.8B, down 4.8% from $60.7B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Creative Planning's Q3 2022 filing shows 223 new, 1,138 increased, 765 reduced and 178 closed positions. Its largest new stake was Greenlane Holdings: 4 shares worth $4.19M. The largest sale was iShares Core S&P 500 ETF, an estimated $168M.
By sector, the portfolio is most concentrated in Technology at 4.4% of assets, down from 4.5% a quarter earlier, followed by Financials and Consumer Discretionary.
- Creative Planning's largest Q3 2022 buy was Greenlane Holdings: 4 shares worth $4.19M.
- Creative Planning added most to Schwab US Large- Cap ETF in Q3 2022, an estimated $445M increase.
- Creative Planning's biggest Q3 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $168M.
- Creative Planning fully exited BNY Mellon US Small Cap Core Equity ETF in Q3 2022, selling an estimated $16.3M.
- Creative Planning's ten largest holdings make up 45% of its $57.8B portfolio in Q3 2022.
- Creative Planning opened 223 new positions and closed 178 in Q3 2022.
- Creative Planning's portfolio value fell 4.8% quarter-over-quarter to $57.8B.
Based on Creative Planning's 13F filing for Q3 2022, filed 3 Nov 2022.